Natalia Sánchez-Arribas

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2021
Publications (10 Years): 5

Top Topics

Regulatory T Cells

Top Venues

Nanomaterials (Basel, Switzerland)

ACS applied materials & interfaces

This page only lists publications with an associated author ORCID identifier.

Publications

Natalia Sánchez-Arribas, María Martínez-Negro, Clara Aicart-Ramos, Concepción Tros de Ilarduya, Emilio Aicart, Andrés Guerrero-Martínez, Elena Junquera
Gemini Cationic Lipid-Type Nanovectors Suitable for the Transfection of Therapeutic Plasmid DNA Encoding for Pro-Inflammatory Cytokine Interleukin-12. Pharmaceutics 13 (5) (2021)
Natalia Sánchez-Arribas, Pablo Díaz-Núñez, José Osío Barcina, Emilio Aicart, Elena Junquera, Andrés Guerrero-Martínez
Controlled pDNA Release in Gemini Cationic Lipoplexes by Femtosecond Laser Irradiation of Gold Nanostars. Nanomaterials (Basel, Switzerland) 11 (6) (2021)
Natalia Sánchez-Arribas, María Martínez-Negro, Eva M Villar, Lourdes Pérez, Emilio Aicart, Pablo Taboada, Andrés Guerrero-Martínez, Elena Junquera
Biocompatible Nanovector of siRNA Consisting of Arginine-Based Cationic Lipid for Gene Knockdown in Cancer Cells. ACS applied materials & interfaces 12 (31) (2020)
Natalia Sánchez-Arribas, María Martínez-Negro, Eva M Villar, Lourdes Pérez, José Osío Barcina, Emilio Aicart, Pablo Taboada, Andrés Guerrero-Martínez, Elena Junquera
Protein Expression Knockdown in Cancer Cells Induced by a Gemini Cationic Lipid Nanovector with Histidine-Based Polar Heads. Pharmaceutics 12 (9) (2020)
María Martínez-Negro, Natalia Sánchez-Arribas, Andrés Guerrero-Martínez, María Luisa Moyá, Concepción Tros de Ilarduya, Francisco Mendicuti, Emilio Aicart, Elena Junquera
A Non-Viral Plasmid DNA Delivery System Consisting on a Lysine-Derived Cationic Lipid Mixed with a Fusogenic Lipid. Pharmaceutics 11 (12) (2019)